|
|
Esteban Celis
J Clin Invest. 2002;
110(12):1765
doi:10.1172/JCI17405
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(6)
| Title and authors |
Publication |
Year |
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells
Angela Wahl, Jon Weidanz, William Hildebrand
|
Expert Rev Proteomics
|
2006 |
NY-ESO-1 immunotherapy for multiple myeloma
Susann Szmania, Guido Tricot, Frits van Rhee
|
Leuk Lymphoma
|
2006 |
Active Antigen-specific Immunotherapy of Melanoma: from Basic Science to Clinical Investigation
Giulio C. Spagnoli, Michel Adamina, Martin Bolli, Walter P. Weber, Paul Zajac, Walter Marti, Daniel Oertli, Michael Heberer, Felix Harder
|
World J Surg
|
2005 |
Recent progress in tumour vaccine development
I Caroline Le Poole, Hemamalini Bommiasamy, W Martin Kast
|
Expert Opin. Investig. Drugs
|
2003 |
Immunity against soft-tissue sarcomas
Robert G. Maki
|
Curr Oncol Rep
|
2003 |
Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy
Kenji Chamoto, Akemi Kosaka, Takemasa Tsuji, Junko Matsuzaki, Takeshi Sato, Tsuguhide Takeshima, Kenji Iwakabe, Yuji Togashi, Toshiaki Koda, Takashi Nishimura
|
Cancer Science
|
2003 |
|
